Gordon Edes doesn't like the Red Sox' moves

Leave a comment

Gordon Edes, late of Yahoo! late of the Boston Globe and now writing for ESPN Boston doesn’t like Red Sox’ recent moves very much. He notes that the Sox don’t usually sign free agent pitchers to big deals. He outlines Lackey’s health history, making what seems like a more aggressive case for Lackey as an injury risk than I’ve seen from anyone else.

Edes’ takeaways: (a) the Red Sox have money to burn and feel that Lackey’s worth the risk; (b) the Sox were kind of improvising here, having not initially planned to go after Lackey but calling the audible once the Bay negotiations hit an impasse; and (c) this could all be a long play to cover for the absence of Josh Beckett, who Edes thinks the Sox may allow to walk next year.

Finally, Edes doesn’t like the Cameron signing. While Buster Olney characterizes it and a potential Adrian Beltre signing as the Sox building “the second best pitching and defense team after the Mariners,” Edes simply worries about whether or not there will be enough pop in the Sox’ lineup.  It’s a legitimate concern.

This doesn’t happen often, but the Sox’ moves yesterday were largely overshadowed by what went down in Lee-Halladay land.  Are these moves as unpopular with Red Sox fans as they appear to be with Edes? Edes usually seems to be sensible about such things, but I feel like he’s being overly harsh here.

Mets sign Matt Kemp to minor league deal

Matt Kemp
Getty Images
1 Comment

The Mets have had a lot of injuries in their outfield. How many? So many that they’re bringing in Matt Kemp, who they just signed on a minor league deal. Hey, why not? He’s functionally free.

Kemp was released by the Reds earlier this month after batting just .200/.210/.283 over 62 plate appearances. While he was a pretty useful player for the first half of the 2018 season for the Dodgers, the odds of him making major contributions to the Mets this year are probably about the same odds there were on Adrián González making an impact when the Mets signed him last year. But again: what’s the harm?